-

Dr. Jim Birchenough Joins Barclays as Co-Head of Global Biopharma Investment Banking

Dr. Birchenough will partner with Alexis de Rosnay, who takes on an expanded role; he also assumes the role of Chairman of Global Healthcare Investment Banking

NEW YORK--(BUSINESS WIRE)--Barclays today announced the appointment of Jim Birchenough, MD, as Chairman of Global Healthcare Investment Banking and Co-Head of Global Biopharma Investment Banking, based in San Francisco.

Dr. Birchenough has over 35 years of life science experience across biopharmaceutical bench research, clinical medicine practice, biotech equity research, and biopharma investment banking. He joins Barclays from Wells Fargo, most recently leading their Biopharma Investment Banking franchise. Prior to that, he spent over 20 years as a leading biotech equity research analyst at Wells Fargo, BMO Capital Markets, Barclays and Lehman Brothers, covering both smaller, development-stage biotech and larger, global biopharma companies.

Birchenough will partner with Alexis de Rosnay, who is taking on an expanded role as Co-Head of Global Biopharma Investment Banking, in addition to his existing responsibilities as Chairman of Global Healthcare Investment Banking. Since joining Barclays a year ago, de Rosnay has significantly expanded Barclays’ life sciences franchise and is successfully leading efforts around a broad range of critical client relationships.

“The wealth of experience and extensive client relationships that Jim and Alexis possess, coupled with their strong track records of growing businesses, will be of huge value as we continue to further expand our coverage footprint in the healthcare sector, in particular with biotech and pharma clients,” said Rick Landgarten, Global Head of Healthcare and Real Estate Investment Banking.

About Barclays Corporate and Investment Bank

Barclays Corporate and Investment Bank is comprised of the Investment Banking, International Corporate Banking, Global Markets and Research businesses. It provides money managers, financial institutions, governments, supranational organisations and corporate clients with services and advice for their funding, financing, strategic and risk management needs. For further information about Barclays Corporate and Investment Bank, please visit our website www.cib.barclays.

Contacts

Press Contacts:
Matt Scully
212-526-7844
matthew.scully@barclays.com

Barclays

LSE:BARC
Details
Headquarters: London, United Kingdon
Website: home.barclays
CEO: C.S. Venkatakrishnan
Employees: 81,600
Organization: PUB
Revenues: £21.9bn (2021)
Net Income: £8.4bn (2021)

Release Versions

Contacts

Press Contacts:
Matt Scully
212-526-7844
matthew.scully@barclays.com

More News From Barclays

Barclays Continues Strategic Investment in Financial Sponsors Group

NEW YORK--(BUSINESS WIRE)--Barclays today announces the appointment of Jason Short as a Managing Director in the Financial Sponsors Group (FSG), based in San Francisco and covering West Coast accounts. Expanding the capabilities with financial sponsor clients is key to the growth of Barclays’ Investment Banking business. In his new role, Jason will be responsible for building and maintaining relationships with financial sponsor clients based on the West Coast and their portfolio company managem...

Barclays Appoints Kieran Whitty as a Co-Head of Healthcare for Europe, Middle East and Africa

LONDON--(BUSINESS WIRE)--Barclays today announces the appointment of Kieran Whitty as Co-Head of Healthcare EMEA (Europe, Middle East and Africa), working alongside Sid Chhibbar, Co-Head of Healthcare EMEA. This appointment reflects Barclays’ effort to continue its growth in the UK and Continental Europe, which is a key focus for Barclays investment bank. Kieran joins Barclays from Bank of America where he spent 18 years, most recently as a Managing Director in the EMEA Healthcare team. He has...

Barclays Appoints Two New Senior Hires Into Its Financial Sponsors Group

NEW YORK--(BUSINESS WIRE)--Barclays announces the appointments of Isobel van Daesdonk and Scott Willard as Managing Directors within the Financial Sponsors Group. Ms. van Daesdonk and Mr. Willard will be based in New York, and will report to Christian Oberle, Head of the Americas Financial Sponsors Group at Barclays. Ms. van Daesdonk is a seasoned Investment Banker with 25 years of experience. She joins Barclays from Guggenheim Securities, where she was a Senior Managing Director in Financial S...
Back to Newsroom